359 related articles for article (PubMed ID: 2245881)
1. Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy.
Cooper ME; Allen TJ; O'Brien RC; Papazoglou D; Clarke BE; Jerums G; Doyle AE
Diabetes; 1990 Dec; 39(12):1575-9. PubMed ID: 2245881
[TBL] [Abstract][Full Text] [Related]
2. Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat.
Cooper ME; Allen TJ; Macmillan PA; Clarke BE; Jerums G; Doyle AE
Diabetologia; 1989 May; 32(5):326-8. PubMed ID: 2546846
[TBL] [Abstract][Full Text] [Related]
3. Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat: are these effects specific for enalapril?
Baba T; Sawicki PT
Diabetologia; 1989 Nov; 32(11):829. PubMed ID: 2556309
[No Abstract] [Full Text] [Related]
4. Genetic hypertension accelerates nephropathy in the streptozotocin diabetic rat.
Cooper ME; Allen TJ; Macmillan P; Bach L; Jerums G; Doyle AE
Am J Hypertens; 1988 Jan; 1(1):5-10. PubMed ID: 2835966
[TBL] [Abstract][Full Text] [Related]
5. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
[TBL] [Abstract][Full Text] [Related]
6. Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats.
Fabris B; Candido R; Armini L; Fischetti F; Calci M; Bardelli M; Fazio M; Campanacci L; Carretta R
J Hypertens; 1999 Dec; 17(12 Pt 2):1925-31. PubMed ID: 10703891
[TBL] [Abstract][Full Text] [Related]
7. The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy.
O'Brien RC; Cooper ME; Jerums G; Doyle AE
Diabetes; 1993 Apr; 42(4):604-9. PubMed ID: 8454112
[TBL] [Abstract][Full Text] [Related]
8. Glomerular abnormalities in long-term experimental diabetes. Role of hemodynamic and nonhemodynamic factors and effects of antihypertensive therapy.
Fujihara CK; Padilha RM; Zatz R
Diabetes; 1992 Mar; 41(3):286-93. PubMed ID: 1551488
[TBL] [Abstract][Full Text] [Related]
9. Renoprotective effect of enalapril in uninephrectomized spontaneously hypertensive rats with neonatal streptozotocin-induced diabetes.
Sato Y; Iwase M; Wakisaka M; Yoshizumi H; Nunoi K; Yoshinari M; Fujishima M
Diabetes Res Clin Pract; 1995 Sep; 29(3):153-61. PubMed ID: 8591707
[TBL] [Abstract][Full Text] [Related]
10. Effects of antihypertensive drugs or glycemic control on antioxidant enzyme activities in spontaneously hypertensive rats with diabetes.
Tang Z; Shou I; Wang LN; Fukui M; Tomino Y
Nephron; 1997; 76(3):323-30. PubMed ID: 9226234
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive therapy in a model combining spontaneous hypertension with diabetes.
Cooper ME; Rumble JR; Allen TJ; O'Brien RC; Jerums G; Doyle AE
Kidney Int; 1992 Apr; 41(4):898-903. PubMed ID: 1513111
[TBL] [Abstract][Full Text] [Related]
12. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
[TBL] [Abstract][Full Text] [Related]
13. Renoprotective differences between perindopril and enalapril in the diabetic hypertensive rat do not reflect glomerular angiotensin-converting enzyme activity.
Duggan KA; Hodge G; Makarious MM; Charlesworth JA
Clin Sci (Lond); 1998 May; 94(5):511-6. PubMed ID: 9682674
[TBL] [Abstract][Full Text] [Related]
14. Diabetic renal microvascular disease: the role of hypertension and ACE inhibitors.
Cooper ME; Rumble JR; Gin T; Lim-Joon T
Clin Exp Pharmacol Physiol Suppl; 1992; 19():23-7. PubMed ID: 1395113
[TBL] [Abstract][Full Text] [Related]
15. Effects of genetic hypertension on diabetic nephropathy in the rat--functional and structural characteristics.
Cooper ME; Allen TJ; O'Brien RC; Macmillan PA; Clarke B; Jerums G; Doyle AE
J Hypertens; 1988 Dec; 6(12):1009-16. PubMed ID: 3221096
[TBL] [Abstract][Full Text] [Related]
16. Reducing blood pressure in SHR with enalapril provokes redistribution of NHE3, NaPi2, and NCC and decreases NaPi2 and ACE abundance.
Yang LE; Leong PK; McDonough AA
Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1197-208. PubMed ID: 17652375
[TBL] [Abstract][Full Text] [Related]
17. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
Estato V; Obadia N; Carvalho-Tavares J; Freitas FS; Reis P; Castro-Faria Neto H; Lessa MA; Tibiriçá E
Microvasc Res; 2013 May; 87():41-9. PubMed ID: 23466285
[TBL] [Abstract][Full Text] [Related]
18. Losartan ameliorates progression of glomerular structural changes in diabetic KKAy mice.
Sasaki M; Uehara S; Ohta H; Taguchi K; Kemi M; Nishikibe M; Matsumoto H
Life Sci; 2004 Jul; 75(7):869-80. PubMed ID: 15183078
[TBL] [Abstract][Full Text] [Related]
19. "Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension.
Ishiguro K; Hayashi K; Sasamura H; Sakamaki Y; Itoh H
Hypertension; 2009 Jan; 53(1):83-9. PubMed ID: 19047581
[TBL] [Abstract][Full Text] [Related]
20. Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy.
Björck S; Mulec H; Johnsen SA; Nyberg G; Aurell M
BMJ; 1990 Apr; 300(6729):904-7. PubMed ID: 2337713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
